|
Montenegro M.F., González-Guerrero R., Sánchez-Del-Campo L., Piñero-Madrona A., Cabezas-Herrera J., Rodríguez-López J.N. Targeting the epigenetics of the DNA damage response in breast cancer. Cell Death and Disease. 7 April 2016. 7. 10.1038/cddis.2016.85
AÑO: 2016; IF: 5.965
|
|
Montenegro M.F., Sánchez-Del-Campo L., Fernández-Pérez M.P., Saéz-Ayala M., Cabezas-Herrera J., Rodríguez-López J.N. Targeting the epigenetic machinery of cancer cells. Oncogene. 8 January 2015. 34:135-143. 10.1038/onc.2013.605
AÑO: 2015; IF: 7.932
|
|
Sáez-Ayala M., Montenegro M.F., Sánchez-del-Campo L., Fernández-Pérez M.P., Chazarra S., Freter R., Middleton M., Piñero-Madrona A., Cabezas-Herrera J., Goding C.R., Rodríguez-López J.N. Directed Phenotype Switching as an Effective Antimelanoma Strategy. Cancer Cell. 8 July 2013. 24:105-119. 10.1016/j.ccr.2013.05.009
AÑO: 2013; IF: 23.893
|
|
Fernández-Pérez M.P., Montenegro M.F., Sáez-Ayala M., Sánchez-del-Campo L., Piñero-Madrona A., Cabezas-Herrera J., Rodríguez-López J.N. Suppression of antifolate resistance by targeting the myosin Va trafficking pathway in melanoma. Neoplasia (United States). July 2013. 15:826-839. 10.1593/neo.13320
AÑO: 2013; IF: 5.398
|
|
Sáez-Ayala M., Fernández-Pérez M.P., Montenegro M.F., Sánchez-del-Campo L., Chazarra S., Piñero-Madrona A., Cabezas-Herrera J., Rodríguez-López J.N. Melanoma coordinates general and cell-specific mechanisms to promote methotrexate resistance. Experimental Cell Research. 10 June 2012. 318:1146-1159. 10.1016/j.yexcr.2012.03.022
AÑO: 2012; IF: 3.557
|